We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Top Buys

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.7M
2
IMVT icon
Immunovant
IMVT
+$15.7M
3
LL
LL Flooring Holdings, Inc.
LL
+$11.4M
4
ACET icon
Adicet Bio
ACET
+$10.9M
5
INVZ icon
Innoviz Technologies
INVZ
+$9.95M

Top Sells

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$131M
2
IMCR icon
Immunocore
IMCR
+$34.1M
3
FTAI icon
FTAI Aviation
FTAI
+$28.1M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$20.8M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOLD
376
CALL
DELISTED
Amicus Therapeutics
FOLD
$12.5K ﹤0.01%
+7,600
New +$85.6K
PDOT.WS
377
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$12.4K ﹤0.01%
265,135
+97,801
+58% +$3.58K
PNTM.WS
378
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$12.4K ﹤0.01%
154,754
-65,246
-30% -$3.53K
BREZW
379
DELISTED
Breeze Holdings Acquisition Corp. Warrant
BREZW
$12.2K ﹤0.01%
+173,979
New +$11.3K
AEON.WS
380
DELISTED
AEON Biopharma Inc
AEON.WS
$12.2K ﹤0.01%
+267,522
New +$10.8K
SKGRW
381
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$11.9K ﹤0.01%
119,290
-12,710
-10% -$1.63K
QQQ icon
382
CALL
Invesco QQQ Trust
QQQ
$478B
$11.9K ﹤0.01%
+5,000
New +$1.38M
CVIIW
383
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$11.9K ﹤0.01%
241,243
+162,352
+206% +$6.98K
PINS icon
384
CALL
Pinterest
PINS
$13.5B
$11.9K ﹤0.01%
+12,500
New +$298K
WU icon
385
PUT
Western Union
WU
$2.19B
$11.6K ﹤0.01%
+45,000
New +$621K
ADOCR
386
DELISTED
Edoc Acquisition Corp. Right
ADOCR
$11.6K ﹤0.01%
+128,808
New +$10.3K
SVNAW
387
DELISTED
7 Acquisition Corp Warrant
SVNAW
$11.4K ﹤0.01%
128,034
+11,900
+10% +$1.08K
HMACR
388
DELISTED
Hainan Manaslu Acquisition Corp. Right
HMACR
$11K ﹤0.01%
99,500
-50,500
-34% -$5.47K
AQUNR
389
DELISTED
Aquaron Acquisition Corp. Rights
AQUNR
$11K ﹤0.01%
+50,000
New +$11.9K
TCOA.WS
390
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$10.7K ﹤0.01%
267,085
+600
+0.2% +$35
GB.WS
391
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
$10.7K ﹤0.01%
+34,337
New +$8.55K
VSACW
392
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
$10.7K ﹤0.01%
364,571
-1,000
-0.3% -$36
GRRRW
393
Gorilla Technology Group Warrant
GRRRW
$1.53M
$10.6K ﹤0.01%
51,904
+2,351
+5% +$666
CLRCW
394
DELISTED
ClimateRock Warrant
CLRCW
$10.6K ﹤0.01%
202,640
-31,845
-14% -$1.58K
ACAXW
395
DELISTED
Alset Capital Acquisition Corp Warrant
ACAXW
$10.6K ﹤0.01%
136,581
-27,600
-17% -$1.97K
PPYAW
396
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$10.5K ﹤0.01%
132,651
+42,300
+47% +$1.93K
VHAQ.WS
397
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$10.5K ﹤0.01%
210,000
-9,200
-4% -$504
CCV.WS
398
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$10.5K ﹤0.01%
+129,676
New +$5.55K
JAQCW
399
DELISTED
Jupiter Acquisition Corporation Warrants
JAQCW
$10.3K ﹤0.01%
172,052
-2,090
-1% -$151
UHGWW
400
DELISTED
United Homes Group Warrant
UHGWW
$9.94K ﹤0.01%
94,687
+20,835
+28% +$2.83K
14 15
16
17 18

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.